Poised to Disrupt Fertility Medicine, TMRW Raises $12M in Series A Financing for Robotic Process Automation Platform Central to Birth of Over 200 Million People NEW YORK, May 29, 2019-- TMRW, the creator of the first Robotic Process Automation (RPA) platform designed specifically for in vitro fertilization (IVF), announced today it had raised over $12M in Series A financing alongside significant additions to its corporate, scientific and advisory boards. The Series A was led by Special Situations' Life Sciences Innovation (LSI) Fund, the first venture vehicle focused on next generation solutions for the fertility industry.